Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Infectious Diseases
Burden of influenza in patients with cardiovascular disease who receive antiviral treatment for influenza
Mitra Corrala Genentech, Inc, South San Francisco, CA, USACorrespondence[email protected]
https://orcid.org/0000-0003-1869-9721
https://orcid.org/0000-0003-1869-9721, Rita de Cassia Castroa Genentech, Inc, South San Francisco, CA, USAhttps://orcid.org/0000-0003-0655-5552
https://orcid.org/0000-0003-0655-5552, Tu My Toa Genentech, Inc, South San Francisco, CA, USAhttps://orcid.org/0000-0001-9506-7539
https://orcid.org/0000-0001-9506-7539, Stella Arndorferb Genesis Research, Hoboken, NJ, USAhttps://orcid.org/0000-0002-6768-7148
https://orcid.org/0000-0002-6768-7148, Shu Wangb Genesis Research, Hoboken, NJ, USAhttps://orcid.org/0000-0002-9328-3710
https://orcid.org/0000-0002-9328-3710 & John Stephensa Genentech, Inc, South San Francisco, CA, USAhttps://orcid.org/0000-0003-0146-4993
https://orcid.org/0000-0003-0146-4993Related Research Data
Burden of influenza in patients with cardiovascular disease who receive antiviral treatment for influenza
Source:
Taylor & Francis
Linking provided by
